WAVE Life Sciences Ltd.
WVE
$6.73
-$0.06-0.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 147.35% | -87.65% | -4.33% | -94.13% | -324.16% |
| Total Depreciation and Amortization | -0.09% | -0.64% | -0.23% | -0.23% | -3.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.13% | 1.32% | 20.96% | 22.49% | 2.98% |
| Change in Net Operating Assets | -914.53% | 4,858.91% | 97.09% | 67.78% | 53.48% |
| Cash from Operations | 6.09% | -69.21% | 17.84% | -0.58% | 3.53% |
| Capital Expenditure | 77.55% | -636.54% | 87.53% | -17.13% | -79.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 77.55% | -636.54% | 87.53% | -17.13% | -79.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.54% | 28,942.27% | -95.50% | -84.56% | 5,526.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.17% | -- | -- | -- | -- |
| Cash from Financing | -82.83% | 31,101.53% | -95.50% | -84.56% | 5,526.47% |
| Foreign Exchange rate Adjustments | -185.83% | 248.15% | -9.46% | -227.59% | 281.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.64% | 682.62% | -38.81% | -132.13% | 283.01% |